A total of 127 institutions have reported a stake in Upstream Bio, Inc. (NASDAQ:UPB) as of December 2025, according to recent 13F filings with the SEC.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FMR LLC | 31 Dec, 2025 | 7,518,202 | -568,211 | -7.03% | $204,119,193.00 |
| ORBIMED ADVISORS LLC | 31 Dec, 2025 | 5,693,589 | 0 | 0.00% | $154,580,941.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 3,344,504 | 740,798 | 28.45% | $90,803,284.00 |
| Decheng Capital LLC | 31 Dec, 2025 | 3,143,078 | -142,215 | -4.33% | $85,334,568.00 |
| NORGES BANK | 31 Dec, 2025 | 2,882,647 | 2,882,647 | 0.00% | $78,263,866.00 |
| Enavate Sciences GP, LLC | 31 Dec, 2025 | 2,459,703 | 0 | 0.00% | $66,780,936.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 2,388,439 | -54,112 | -2.22% | $64,846,119.00 |
| UBS Group AG | 31 Dec, 2025 | 1,806,243 | 1,533,972 | 563.40% | $49,039,498.00 |
| JANUS HENDERSON GROUP PLC | 31 Dec, 2025 | 1,527,958 | 1,527,958 | 0.00% | $41,422,941.00 |
| Altshuler Shaham Ltd | 31 Dec, 2025 | 1,341,540 | -75,282 | -5.31% | $36,422,811.00 |
| Bain Capital Life Sciences Investors, LLC | 31 Dec, 2025 | 1,329,544 | -1,109,994 | -45.50% | $36,097,120.00 |
| Omega Fund Management, LLC | 31 Dec, 2025 | 1,326,293 | -30,000 | -2.21% | $36,008,855.00 |
| STATE STREET CORP | 31 Dec, 2025 | 1,319,226 | 204,645 | 18.36% | $35,816,986.00 |
| VR Adviser, LLC | 31 Dec, 2025 | 1,169,298 | 0 | 0.00% | $31,746,441.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 894,733 | -230,662 | -20.50% | $24,292,001.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 851,908 | 34,799 | 4.26% | $23,134,004.00 |
| Pictet Asset Management Holding SA | 31 Dec, 2025 | 773,148 | 773,148 | 0.00% | $20,990,968.00 |
| Woodline Partners LP | 31 Dec, 2025 | 760,252 | 158,000 | 26.23% | $20,640,842.00 |
| Integral Health Asset Management, LLC | 31 Dec, 2025 | 750,000 | 175,000 | 30.43% | $20,362,500.00 |
| TCG Crossover Management, LLC | 31 Dec, 2025 | 743,886 | -1,373,217 | -64.86% | $20,196,505.00 |